Literature DB >> 3203051

The effect of antacids and metoclopramide on omeprazole absorption and disposition.

C W Howden1, J L Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3203051      PMCID： PMC1386462          DOI： 10.1111/j.1365-2125.1988.tb05271.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Lack of effect of antacids on plasma concentrations of omeprazole given as enteric-coated granules.

Authors:  H A Tuynman; H P Festen; K Röhss; S G Meuwissen
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

2.  Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man.

Authors:  C W Howden; J A Forrest; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

3.  High dose of antacid (Mylanta II) reduces bioavailability of ranitidine.

Authors:  G W Mihaly; A T Marino; L K Webster; D B Jones; W J Louis; R A Smallwood
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09

4.  Antacids inhibit absorption of cimetidine.

Authors:  W M Steinberg; J H Lewis; D M Katz
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

5.  Oral pharmacokinetics of omeprazole.

Authors:  C W Howden; P A Meredith; J A Forrest; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide.

Authors:  J Behar; G Ramsby
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients.

Authors:  S M Fink; R C Lange; R W McCallum
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

8.  Impaired cimetidine absorption due to antacids and metoclopramide.

Authors:  R Gugler; M Brand; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
  8 in total
  6 in total

1.  Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.

Authors:  M S Ching; G W Mihaly; P W Angus; D J Morgan; S Devenish-Meares; N D Yeomans; R A Smallwood
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 2.  Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.

Authors:  M Lazzaroni; G Bianchi Porro
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 3.  Pharmacokinetic drug interactions with gastrointestinal motility modifying agents.

Authors:  J M Greiff; D Rowbotham
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

Review 4.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 5.  Drug-drug interaction profiles of proton pump inhibitors.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Clin Pharmacokinet       Date:  2010-08       Impact factor: 6.447

Review 6.  Clinical pharmacology of omeprazole.

Authors:  C W Howden
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.